TABLE 5.

Factors associated with the clinical range of depression in adolescent COVID‐19 survivors (n = 74)

	Unadjusted OR (95% CI)	p	Adjusted OR (95% CI)	p
Gender (girl)	1.146 (0.399–3.288)	.800	‐
Age (years)	1.148 (0.854–1542)	.361	‐
Duration of hospitalization (days)	1.041 (0.922–1.176)	.517	‐
Duration a (months)	0.863 (0.688–1.082)	.201	.754 (0.434–1.308)	.315
UCLA loneliness scores	1.141 (1.068–1.219)	<.001	1.123 (1.009–1.249)	.033
RCADS‐total anxiety scores	1.193 (1.097–1.298)	<.001	1.205 (1.080–1.345)	.001
Parents' depression scores b	1.107 (1.024–1.196)	.010	.841 (0.664–1.065)	.152
Parents' anxiety scores b	1.103 (1.022–1.192)	.012	1.314 (1.037–1.665)	.024
CRP positivity	1.944 (0.677–5.584)	.217	1.212 (0.142–10.315)	.861
Neutrophil/lymphocyte ratio	1.037 (0.841–1.279)	.734	‐
Monocyte/lymphocyte ratio	4.369 (0.308–61.926)	.276	‐
Systemic immune‐inflammation index	1.00 (0.99–1.001)	.999	‐

Abbreviations: CRP, C‐reactive protein (mg/L); RCADS, Revised Children's Anxiety and Depression Scale. p‐values <.05 are shown in bold type.

^a After COVID‐19 infection to psychiatric assessment.

^b Depression and Anxiety Stress Scale. (DASS‐21).